Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| CAL-85-1 | Alvocidib | 0.316227766017 | -0.0069 | 0.05022 |
| CAL-85-1 | Alvocidib | 0.316227766017 | -0.0633 | 0.04740 |
| CAL-85-1 | Alvocidib | 0.316227766017 | 0.0610 | 0.05422 |
| CAL-85-1 | Alvocidib | 1.0 | -0.1681 | 0.09893 |
| CAL-85-1 | Alvocidib | 1.0 | -0.1516 | 0.03710 |
| CAL-85-1 | Alvocidib | 1.0 | -0.3171 | 0.12758 |
| CAL-85-1 | GSK2334470 | 0.001 | 0.9660 | 0.00662 |
| CAL-85-1 | GSK2334470 | 0.001 | 0.9542 | -0.00358 |
| CAL-85-1 | GSK2334470 | 0.001 | 0.9424 | -0.00501 |
| CAL-85-1 | GSK2334470 | 0.00316227766017 | 1.0569 | -0.00749 |
| CAL-85-1 | GSK2334470 | 0.00316227766017 | 0.8654 | -0.01008 |
| CAL-85-1 | GSK2334470 | 0.00316227766017 | 0.7631 | 0.01041 |
| CAL-85-1 | GSK2334470 | 0.01 | 0.7411 | -0.00503 |
| CAL-85-1 | GSK2334470 | 0.01 | 0.6752 | -0.00429 |
| CAL-85-1 | GSK2334470 | 0.01 | 0.5810 | 0.00072 |
| CAL-85-1 | GSK2334470 | 0.0316227766017 | 0.8458 | 0.00493 |
| CAL-85-1 | GSK2334470 | 0.0316227766017 | 0.8417 | -0.00695 |
| CAL-85-1 | GSK2334470 | 0.0316227766017 | 0.7615 | -0.00079 |
| CAL-85-1 | GSK2334470 | 0.1 | 0.9844 | -0.00468 |
| CAL-85-1 | GSK2334470 | 0.1 | 0.9443 | -0.00212 |
| CAL-85-1 | GSK2334470 | 0.1 | 0.7674 | 0.01028 |
| CAL-85-1 | GSK2334470 | 0.316227766017 | 0.7030 | -0.00075 |
| CAL-85-1 | GSK2334470 | 0.316227766017 | 0.8265 | -0.00205 |
| CAL-85-1 | GSK2334470 | 0.316227766017 | 0.7779 | 0.00740 |
| CAL-85-1 | GSK2334470 | 1.0 | 0.8079 | 0.00047 |